[A long-term survivor after relapsed acute myeloblastic leukemia with anthracycline dilated cardiomyopathy].
Gan To Kagaku Ryoho
; 35(6): 1021-4, 2008 Jun.
Article
em Ja
| MEDLINE
| ID: mdl-18633238
ABSTRACT
We watched and analyzed patient cardiac functions especially with a "Phased tracking method" to detect rapid motion of the heart. The patient suffered from congestive heart failure while depending on anthracycline cumulative doses, but now has been living more than 10 years after relapsed acute myeloblastic leukemia. To avoid congestive heart failure with increasing highly tumoricidal anthracycline doses, cardiac function should be monitored closely in connection with treatment schedules and proposed accurate therapeutic index.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Cardiomiopatia Dilatada
/
Leucemia Mieloide Aguda
/
Antraciclinas
Tipo de estudo:
Diagnostic_studies
Limite:
Aged
/
Female
/
Humans
Idioma:
Ja
Ano de publicação:
2008
Tipo de documento:
Article